logo-loader
viewTruTrace Technologies Inc

TruTrace welcomes Tilray to Phase 2 of its Shoppers Drug Mart cannabis verification program

The program is expected to help researchers and clinicians match therapeutic outcomes to specific genetic and chemical profiles

Dried cannabis in a pill container
"Tilray has maintained a keen focus on the importance of quality medical cannabis, from their clinical research initiatives to their strategic partnerships in the global medical market," TruTrace CEO Robert Galarza said

TruTrace Technologies Inc (CSE:TTT) (OTCMKTS:TTTSF) announced Wednesday that its medical cannabis verification pilot program with Shoppers Drug Market has added another industry player: Tilray Inc (NASDAQ:TLRY).

Tilray Canada, a subsidiary, joins a slate of companies lined up to use TruTrace’s StrainSecure technology to track strains of medical cannabis and verify their authenticity. 

The program is expected to help researchers and clinicians match therapeutic outcomes to specific genetic and chemical profiles, and provide physicians, pharmacists, and patients with greater confidence in the products they prescribe or consume.

READ: TruTrace: Aphria joins Phase 2 of Shoppers Drug Mart medical cannabis verification program

The latest addition comes a few weeks after TruTrace announced the completion of Phase 1 of the program. Looking ahead, implementation of the program is expected by November. 

TruTrace CEO Robert Galarza was pleased to have a company of Tilray’s calibre on board.

"Tilray has maintained a keen focus on the importance of quality medical cannabis, from their clinical research initiatives to their strategic partnerships in the global medical market," Galarza said in a statement. "We are very excited to begin working with them in the pilot program, and we believe our blockchain-enabled verification and traceability of their products will only further bolster their global brand."

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Quick facts: TruTrace Technologies Inc

Price: 0.105 CAD

CSE:TTT
Market: CSE
Market Cap: $8.42 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of TruTrace Technologies Inc named herein, including the promotion by the Company of TruTrace Technologies Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: TruTrace strikes partnership with Clever Leaves for...

TruTrace Technologies (CSE: TTT-OTCMKTS: BKKSF) CEO Robert Galarza joined Steve Darling from Proactive in Toronto with news the company is forging a partnership with Colombian cannabis company Clever Leaves. That company will be implementing the StrainSecure platform. Galarza discusses how...

14 hours, 49 minutes ago

2 min read